Toxicologists employ various strategies to address these challenges, including the use of biomarkers to monitor immune responses and the application of pharmacodynamic models to predict the outcomes of antigen-antibody interactions. Advances in immunoassays and imaging technologies also enhance the ability to study these complexes in vivo, providing insights into their role in toxicological processes.
